CRANBURY, N.J.; Jan. 24, 2023 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, today announced the expansion of its analytical laboratory and services. The new laboratory is located in the same office park as Experic’s headquarters in Cranbury, […]
Read MoreCRANBURY, N.J.; November 30, 2022 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry, today announced the closing of a $14 million series B capitalization led by Harro Höfliger Packaging Systems, Inc. and East Seattle Partners. In addition, Experic has […]
Read MoreTORONTO (PRWEB) NOVEMBER 10, 2022 – There are a variety of reasons why companies want to accelerate pharma development & manufacturing timelines: to produce drug products for a clinical trial, make products for compassionate use, or meet a management commitment to serve patients, etc. While the primary motivating factor may differ […]
Read MoreCRANBURY, N.J., Sept. 20, 2022 (Business Wire) – Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the pharmaceutical industry, today announced the appointment of Derek Hennecke as an independent member of its board of directors. “Mr. Hennecke’s distinctive combination of experience as an entrepreneur, board […]
Read MoreTORONTO – OCTOBER 12, 2021 – A robust approach for combination drug product development requires an understanding of the drug product characteristics, the effects of processing and device design and how they impact product performance. Risk management connects the dots and interactions of these critical factors. A key component of risk […]
Read MoreTORONTO – JUNE 24, 2021 – As a combination drug product development project moves from the laboratory into production to generate supplies for clinical research, it is necessary to involve multiple functions including manufacturing, engineering and analytical support to make and release these materials. This is especially true for inhalation and […]
Read MoreCranbury, N.J., May 18, 2021– Experic, a contract development and manufacturing organization (CDMO/CMO) and clinical supply services company serving the pharmaceutical industry, today announced that its board of directors has named David Wood as chairman and chief executive officer. “We are thrilled to have Dave accept this leadership role at Experic,” […]
Read MoreCHICAGO – December 17, 2020 – EVERSANA™, the pioneer of next-generation commercial services to the life sciences industry, and Experic, a contract manufacturing organization (CMO) and pharmaceutical supply service company, today announced a collaboration to optimize clinical development, manufacturing, launch planning and commercialization efforts for life sciences companies. Under the […]
Read MoreThe Market got very excited this week—right before market open on Monday—as global drug giant Pfizer (NYSE:PFE) and their partner BioNtech (NASDAQ:BNTX) announced their mRNA vaccine was 90% effective in preventing COVID-19… Read more
Read MoreAUSTIN, Texas–(BUSINESS WIRE)–Oct. 26, 2020– TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it has expanded its engagement with one of its Contract Manufacturing Organization (CMOs), Experic, LLC, […]
Read More